Factors associated with hospitalization for seasonal influenza in Morocco
Eastern Mediterranean Health Journal · 2023
DOI: 10.26719/emhj.23.072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eastern Mediterranean Health Journal, 2023. Verfasst von Hind Ezzine und 13 weiteren Autor:innen. Beteiligte Einrichtung: Research Center, Laboratory of Biodiversity, Ecology and Genome. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines, Influenza A Virus, H1N1 Subtype. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Gefördert von: World Health Organization.
Abstract (Originalsprache)
Background
Morocco is actively working towards expanding its influenza vaccine policy to cover high-risk groups, as recommended by the World Health Organization (WHO).
Aims
We assessed the risk factors for influenza-associated hospitalization for severe acute respiratory infections (SARI) that occurred during the last 5 seasons.
Methods
We conducted a retrospective, analytical study among patients recruited in the ambulatory and hospital sites of the influenza sentinel surveillance system in Morocco between 2014 and 2019. Using multiple logistic regression, we compared the characteristics of influenza-positive patients with SARI to those with influenza-like illness (ILI) to identify factors associated with severe disease.
Results
We included 1323 positive influenza patients with either SARI (41.7%) or ILI diagnosis (58.3%). A(H1N1)pdm09, A(H3N2) and influenza B, respectively, contributed 49.2%, 29.5% and 20.6% of the cases. The main risk factors considered in the bivariate analysis were found in the multivariate analysis to be significantly associated with influenza-related hospitalization (SARI): age < 2 years (aOR = 7.08, P < 0.001); age ≥ 65 years (aOR = 3.59, P < 0.001); diabetes (aOR = 1.98, P = 0.017); obesity (aOR = 2.94, P = 0.034); asthma or chronic respiratory disease (aOR = 4.99, P < 0.001); chronic renal failure (aOR = 4.74, P = 0.005); pregnancy (aOR = 7.49, P < 0.001); and the A(H1N1)pdm09 subtype (aOR = 1.82, P < 0.001).
Conclusion
This study provides epidemiological evidence for the expected benefit of an influenza vaccination strategy for high-risk groups as recommended by the WHO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center, Laboratory of Biodiversity, Ecology and Genome.
- Directorate of Epidemiology and Disease Control, Ministry of Health, Morocco.
- National Influenza Center, National Institute of Hygiene, Ministry of Health, Rabat, Morocco.
- Laboratory of Microbiology and Molecular Biology, Faculty of Sciences, University Mohammed V, Rabat, Morocco.
- World Health Organization Country Office, Rabat, Morocco.
- World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Förderung
- World Health Organization
Zitieren
APA
Ezzine, H., Regragui, Z., Cherkaoui, I., Naciri, M., Filali-Maltouf, A., Rguig, A., Triki, S., Elkholy, A., Bimouhen, A., Falaki, F., Ihazmad, H., Benamar, T., Oumzil, H., & Youbi, M. (2023). Factors associated with hospitalization for seasonal influenza in Morocco. Eastern Mediterranean Health Journal. https://doi.org/10.26719/emhj.23.072
Vancouver
Ezzine H, Regragui Z, Cherkaoui I, Naciri M, Filali-Maltouf A, Rguig A, et al. Factors associated with hospitalization for seasonal influenza in Morocco. Eastern Mediterranean Health Journal. 2023. doi:10.26719/emhj.23.072
BibTeX
@article{Ezzine2023,
author = {Ezzine, Hind and Regragui, Zakia and Cherkaoui, Imad and Naciri, Mariam and Filali-Maltouf, Abdelkarim and Rguig, Ahmed and Triki, Soumia and Elkholy, Amgad and Bimouhen, Abderrahman and Falaki, Fatima and Ihazmad, Hassan and Benamar, Touria and Oumzil, Hicham and Youbi, Mohammed},
title = {Factors associated with hospitalization for seasonal influenza in Morocco},
journal = {Eastern Mediterranean Health Journal},
year = {2023},
doi = {10.26719/emhj.23.072}
}
EUVIMED